Skip to main content

Table 1 Clinical characteristics of the critically ill ICU patients assessed

From: B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients

  SIRS (n = 28) Sepsis (n = 11)
Age 59.8 (3.8) 58.4 (7.2)
Male gender 17 (60.7%) 6 (54.5%)
APACHE II score 16.6 (4 to 29) 20.0 (5 to 26)
Patients from trauma ICU 11 (39.3%) 5 (45.4%)
Patients from surgical ICU 17 (60.7%) 6 (54.6%)
Average hospital length of stay (days) 31.1 (5.1) 58.4* (10.5)
Site of infection   
 Lung   5 (45.4%)
 Blood   2 (18.2%)
 Abdominal   1 (9.1%)
 Urinary tract   1 (9.1%)
 Skin   1 (9.1%)
 Catheter   1 (9.1%)
Subsequent nosocomial infection 11 (39.2%) 8 (72.7%)
Site of infection   
 Lung 3 (27.3%) 4 (50%)
 Abdominal 1 (9.1%) 0 (0%)
 Urinary tract 5 (45.4%) 3 (37.5%)
 Skin 2 (18.2%) 1 (10%)
Sampling time following ICU admission (days) 4 (0 to 45) 21 (3 to 83)
Days following subsequent infection   
 Following ICU admission   31.7 (9 to 94)
 Following sampling   22.38 (6 to 49)
  1. Data presented as mean (standard error of the mean), number (%) or median (range). APACHE, Acute Physiology and Chronic Health Evaluation; SIRS, systemic inflammatory response syndrome. *P <0.05 via an unpaired, two-tailed Student’s t test.